Status:
COMPLETED
COroNary CT Angiography Evaluation For Clinical Outcomes: An InteRnational Multicenter Registry (CONFIRM)
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Atherosclerosis
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
The CONFIRM study was developed to examine the prognostic value of cardiac computed tomographic angiography (CCTA) findings for prediction of future adverse cardiac events related to coronary artery d...
Detailed Description
Coronary computed tomographic angiography (CCTA) of 64-detector rows or greater represents a novel noninvasive anatomic method for evaluation of patients with suspected coronary artery disease (CAD). ...
Eligibility Criteria
Inclusion
- All consecutive patients at cluster sites meeting all inclusion criteria undergoing CCTA of 64-detector rows or greater will be included within the CONFIRM registry.
- Age \> 18 years
- Evaluation by CCTA with 64-detector rows or greater for CAD evaluation as part of standard of care
- Interpretable CCTA
- Prospective data collection for CAD risk factors.
Exclusion
- No explicit patient exclusion criteria are defined.
Key Trial Info
Start Date :
June 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
34000 Patients enrolled
Trial Details
Trial ID
NCT01443637
Start Date
June 1 2003
End Date
March 1 2016
Last Update
January 13 2022
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048
2
Cardiovascular Medical Group of Southern California
Los Angeles, California, United States, 90210
3
Harbor UCLA
Los Angeles, California, United States, 90502
4
Walter Reed Army Medical Center
Washington D.C., District of Columbia, United States, 20889